APA (7th ed.) Citation

X, S., X, N., MM, M., K, L., IS, d. l. C., J, D., . . . N, V. (2024). Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of age: A Phase 1/2 Randomized Trial. The Journal of infectious diseases, 229(1), 95. https://doi.org/10.1093/infdis/jiad271

Chicago Style (17th ed.) Citation

X, Sáez-Llorens, et al. "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of Age: A Phase 1/2 Randomized Trial." The Journal of Infectious Diseases 229, no. 1 (2024): 95. https://doi.org/10.1093/infdis/jiad271.

MLA (9th ed.) Citation

X, Sáez-Llorens, et al. "Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6-7 Months of Age: A Phase 1/2 Randomized Trial." The Journal of Infectious Diseases, vol. 229, no. 1, 2024, p. 95, https://doi.org/10.1093/infdis/jiad271.